StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.77+0.28 (+2.67%)

Close on Nov 18, 2026Market cap $593.30MP/E –Yield –

Sight Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Sight Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$23.24M. For fiscal 2025 it was -$29.69M. The highest annual figure on record is -$22.35M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$29.69M–
FY2024Dec 31, 2024-$22.35M–
FY2023Dec 31, 2023-$47.18M–
FY2022Dec 31, 2022-$75.97M–
FY2021Dec 31, 2021-$52.54M–
FY2020Dec 31, 2020-$32.17M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.66M–
Q1 FY2026Mar 31, 2026-$7.03M–
Q4 FY2025Dec 31, 2025-$1.83M–
Q3 FY2025Sep 30, 2025-$8.72M-2508.6%
Q2 FY2025Jun 30, 2025-$7.54M–
Q1 FY2025Mar 31, 2025-$11.61M–
Q4 FY2024Dec 31, 2024-$3.46M–
Q3 FY2024Sep 30, 2024$362.00K–
Q2 FY2024Jun 30, 2024-$9.47M–
Q1 FY2024Mar 31, 2024-$9.79M–
Q4 FY2023Dec 31, 2023-$6.48M–
Q3 FY2023Sep 30, 2023-$9.83M–
Q2 FY2023Jun 30, 2023-$13.49M–
Q1 FY2023Mar 31, 2023-$17.38M–
Q4 FY2022Dec 31, 2022-$15.50M–
Q3 FY2022Sep 30, 2022-$20.19M–
Q2 FY2022Jun 30, 2022-$18.31M–
Q1 FY2022Mar 31, 2022-$21.97M–
Q4 FY2021Dec 31, 2021-$10.72M–
Q3 FY2021Sep 30, 2021-$16.51M–
Q2 FY2021Jun 30, 2021-$12.44M–
Q1 FY2021Mar 31, 2021-$12.87M–
Q4 FY2020Dec 31, 2020-$8.55M–
Q3 FY2020Sep 30, 2020-$8.62M–

More Sight Sciences figures

See a number that looks wrong?